Document is current
Any future updates will be listed below
-
Authors
Canakis, Andrew
Kolachana, Sindhura
Holden, Van K.
Cross, Raymond K.
- License Information
-
More Information
Article History
Accepted: 5 December 2022
First Online: 21 January 2023
Declarations
:
: Raymond K. Cross has received income from consulting and participation in advisory boards for Abbvie, Adiso, BMS, Fresenius Kabi, Janssen, Magellan Health, Pfizer, and Samsung Bioepis. Drs. Canakis, Kolachana, and Holden declare no relevant funding.
: None.
